Sinovac 4Q earnings show busy China FDA trial calendar; PPD opens Shanghai lab;

> Sinovac's 4Q earnings report shows a busy clinical trials calendar with China FDA. Release

> PPD Laboratories announced the opening of a central lab in Shanghai "equipped with cutting-edge analytical equipment to provide high-quality data across a wide range of technologies and applications for all phases of pharmaceutical development." Release

> Eisai and Arena Pharmaceuticals ($ARNA) completed registration trials for a release formulation of Lorcaserin. Release

> Taiwan's TWi Pharmaceuticals says its U.S. unit has sales licenses from all 50 states. Release

> Baxter ($BAX) submitted BAX 855 to Japan's MHLW for approval. Release

> Singapore's A*STAR Genome Institute found a genetic cause for the prevalence of psoriasis among Caucasians over Chinese. Release

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.